Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Director departure
Appointed director
|
|
Summit Therapeutics Inc. (SMMT)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/13/2023 |
4/A
| Zanganeh Mahkam (Co-CEO & President) has filed a Form 4 on Summit Therapeutics Inc.|
Txns:
| Bought 16,778,415 shares
@ $1.05, valued at
$17.6M
Bought 6,748,629 shares
@ $1.05, valued at
$7.1M
|
|
| 03/08/2023 |
4/A
| Dhingra Ankur (CFO) has filed a Form 4 on Summit Therapeutics Inc.|
Txns:
| Bought 13,027 shares
@ $0.97, valued at
$12.6k
Bought 24,658 shares
@ $0.97, valued at
$23.9k
|
|
|
|